Alpha1-Antitrypsin in Urinary Extracellular Vesicles: A Potential Biomarker of Diabetic Kidney Disease Prior to Microalbuminuria

Alpha1-Antitrypsin in Urinary Extracellular Vesicles: A Potential Biomarker of Diabetic Kidney Disease Prior to Microalbuminuria

Jing Ning, Zhicong Xiang, Chongxiang Xiong, Qin Zhou, Xin Wang, Hequn Zou Department of Nephropathy, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, People’s Republic of ChinaCorrespondence: Hequn ZouDepartment of Nephropathy, The Third Affiliated Hospital o...

Full description

Bibliographic Details
Main Authors:	Ning J, Xiang Z, Xiong C, Zhou Q, Wang X, Zou H
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-06-01
Series:	Diabetes, Metabolic Syndrome and Obesity
Subjects:	diabetic kidney disease urinary extracellular vesicles biomarker alpha1-antitrypsin inflammation tubular epithelial cell
Online Access:	https://www.dovepress.com/alpha1-antitrypsin-in-urinary-extracellular-vesicles-a-potential-bioma-peer-reviewed-article-DMSO

Similar Items

Alpha-1 antitrypsin deficient individuals have circulating extracellular vesicles with profibrogenic cargo
by: Nazli Khodayari, et al.
Published: (2020-09-01)

Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration
by: Elia Bari, et al.
Published: (2019-08-01)

Expert Perspectives on the Management of Alpha 1-Antitrypsin Deficiency
by: Bebiana Conde, et al.
Published: (2022-07-01)

PROINFLAMMATORY CYTOKINE PROFILE IN PATIENTS WITH DIFFERENT ALPHA-1-ANTITRYPSIN PHENOTYPES
by: M. Yu. Pervakova, et al.
Published: (2016-12-01)

Cigarette smoke exposed airway epithelial cell-derived EVs promote pro-inflammatory macrophage activation in alpha-1 antitrypsin deficiency
by: Nazli Khodayari, et al.
Published: (2022-09-01)

Urinary Extracellular Vesicles for Renal Tubular Transporters Expression in Patients With Gitelman Syndrome
by: Chih-Chien Sung, et al.
Published: (2021-06-01)

The Alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosis
by: Dawid Kościołek, et al.
Published: (2024-02-01)

The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry
by: Tobias Meischl, et al.
Published: (2023-01-01)

Polymorphism of alpha-1-antitrypsin in hematological malignancies
by: Aleksandra Topic, et al.
Published: (2009-01-01)

Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review
by: Ilaria Ferrarotti, et al.
Published: (2024-02-01)

Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic
by: Herth FJF, et al.
Published: (2021-11-01)

Case report of a novel alpha1-antitrypsin null variant in Türkiye: Q0RİZE
by: Dilek Karadoğan, et al.
Published: (2024-02-01)

Detection of alpha-1 antitrypsin deficiency: the past, present and future
by: Mark Brantly, et al.
Published: (2020-04-01)

Effect of alpha-1antitrypsin,adiponectine,leptein in obesity
by: Halla G. Mahmood
Published: (2014-01-01)

Alpha 1 antitrypsin distribution in an allergic asthmatic population sensitized to house dust mites
by: I. Suárez-Lorenzo, et al.
Published: (2018-11-01)

Augmentation therapy with human alpha-1-proteinase inhibitor reduces exacerbations in patient with bronchiectasis and alpha-1-antitrypsin deficiency
by: Emanuel Buck, et al.
Published: (2022-01-01)

The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
by: Dunlea DM, et al.
Published: (2018-03-01)

Alpha-1 antitrypsin deficiency: outstanding questions and future directions
by: María Torres-Durán, et al.
Published: (2018-07-01)

Long-term augmentation therapy with Alpha-1 Antitrypsin in an MZ-AAT severe persistent asthma
by: I. Blanco, et al.
Published: (2016-01-01)

Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
by: Marc Miravitlles, et al.
Published: (2022-12-01)

Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil
by: Rodrigo Russo, et al.

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
by: Chapman KR, et al.
Published: (2018-01-01)

Proteomic Analysis of Exosomes Secreted from Human Alpha-1 Antitrypsin Overexpressing Mesenchymal Stromal Cells
by: Hua Wei, et al.
Published: (2021-12-01)

The Study of Alterations of alpha – 1 – Antitrypsin (1-AT) in Serum of Hypothyroid Patients
by: Alireza Kheirollah, et al.
Published: (1998-09-01)

The patient profile of individuals with Alpha-1 antitrypsine gene mutations at a referral center in Brazil
by: Manuela Brisot Felisbino, et al.

Alpha-1-Antitrypsin Deficiency in Children: Case Series
by: Svetlana I. Melnik, et al.
Published: (2016-12-01)

Methods of Purification and Application Procedures of Alpha1 Antitrypsin: A Long-Lasting History
by: Simona Viglio, et al.
Published: (2020-09-01)

Alpha 1 antitrypsin deficiency in non cystic fibrosis bronchiectasis
by: Mohamed Shahat Badawy, et al.
Published: (2013-04-01)

Assessing the efficacy of Alpha1-Proteinase inhibitor (human) augmentation therapy for Alpha1-Antitrypsin deficiency – Related emphysema: Challenges and opportunities
by: L. Ross Pierce
Published: (2024-06-01)

The Role of Urinary Extracellular Vesicles in Kidney Cancer: Diagnostic and Therapeutic Potential
by: Kirk Gallego
Published: (2024-07-01)

Future Perspectives in the Diagnosis and Treatment of Liver Disease Associated with Alpha-1 Antitrypsin Deficiency
by: Nélia Abreu, et al.
Published: (2023-02-01)

Recommendations for the diagnosis and treatment of alpha-1 antitrypsin deficiency
by: Paulo Henrique Ramos Feitosa, et al.
Published: (2024-12-01)

Cellular Consequences of Z Alpha-1 Antitrypsin Accumulation and Prospects for Therapy
by: Sam Alam, et al.
Published: (2013-12-01)

Anxiety and depression in patients with alpha-1 antitrypsin deficiency: current insights and impact on quality of life
by: Beiko T, et al.
Published: (2019-07-01)

Clinical presentations of four patients with rare Alpha 1 Antitrypsin variants identified in a single US center
by: Friedrich Kueppers
Published: (2021-01-01)

Low Prevalence of Mild Alpha-1-Antitrypsin Deficiency in Hospitalized COVID-19-Patients
by: Nygren D, et al.
Published: (2022-06-01)

Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence
by: Franck F. Rahaghi, et al.
Published: (2017-05-01)

Protective role of the alpha-1-antitrypsin in intervertebral disc degeneration
by: Weikun Liu, et al.
Published: (2021-08-01)

The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO
by: Robert A. Stockley, et al.
Published: (2023-08-01)

Comparison The Activity Rate of Alpha-1 Antitrypsin in Obese with normal weight People
by: farzad roshanzamir, et al.
Published: (2014-05-01)